Regeneron Pharmaceuticals, Inc (USA) Posted July 30, 2026

Director Precision Medicine

Armonk, United States Full time
Director

Regeneron Pharmaceuticals, Inc (USA) is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Build our future together:

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Precision Medicine Strategy Lead (Director level) to join our Precision Medicine group, independently overseeing the development and execution of biomarker strategies across one or more therapeutic areas, with a preference for obesity/metabolism, as well as Neurodegenerative Disorders, Cardiovascular Disease, Muscle and Metabolism Disorders, and/or Rare Genetic Diseases. In this highly matrixed role, you will design, develop, communicate, and operationally implement clinical biomarker strategies, collaborating with discovery research, clinical operations, internal laboratories, and allied company partners to support key programs in early and late-stage drug development.

This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.

When & where:

Location: Tarrytown, NY

Work model/flexibility: Onsite

Discover your role:

Lead the strategic vision for clinical biomarkers in one or more therapeutic areas, enabling advances in target identification, indication selection, and patient stratification

Serve as a senior-level Precision Medicine representative on development teams, delivering biomarker strategies from concept to execution and results interpretation

Collaborate with Discovery Research and product development teams to incorporate biomarker strategies for molecules in discovery phases

Represent Regeneron with allied companies to develop and implement biomarker strategies for partnered alliances

Partner with clinical operations teams to implement biomarker and exploratory sample collection and analyses across studies

Design, oversee, and manage internal and external research collaborations in clinical technologies and translational research

Ensure complex clinical assays are fit-for-purpose, whether developed and validated internally or externally

Contribute to and ensure the quality of technical reports, study memos, clinical study reports, and scientific publications

This role requires:

Ph.D. and 10+ years of experience driving, managing, executing, and delivering results for complex, multi-functional projects

Excellent communication and presentation skills, with high emotional intelligence

Strong organizational and team collaboration skills

Strong track record in mentorship and development of direct reports

Deep experience in biomarker assay development and validation in clinical drug development, with a focus in therapeutic areas outside of Oncology

Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all  qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.

Where necessary, we disclose salary ranges for roles in all countries in which we operate.  The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits.  Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits. For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/ . For other locations, additional information will be provided during the recruitment process.  If you have any questions, please speak with your recruiter.

Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on‑site. Please speak with your recruiter and hiring manager for more information about on‑site expectations for your role and location.

As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.

For jobs in Canada: this posting is for an existing position.

Salary Range (annually)

$205,000.00 - $341,600.00

Job details

Seniority
Director
Function
Not listed
Therapeutic area
Not listed
Location
Armonk, United States
Employment type
Full time

How this role compares

Computed from every other active role in our database, not just this employer's listings.

We don't have enough classified peer data for this role yet, so there's no comparison to show. This happens when a posting's title/category doesn't match any taxonomy rule -- it's excluded rather than compared against the wrong peer group.